MP01: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I

Room 228
Moderated Poster
Voiding Dysfunction/BPH

Information

Format
In PersonOn Demand

MP01: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I

MP01-01: Exime&[reg] urethral stent implantation (EUSI) as initial treatment for patients presenting with acute urinary retention (AUR) for the first time as a result of BPH

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Nordine Amara

MP01-02: The "Butterfly" transurethral retraction device for BPH – over 1 year follow up

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Ran Katz · Ziv Medical Center

MP01-03: Transurethral ultrasound ablation for benign prostatic hyperplasia: three-month clinical outcomes of a phase 1-2 study

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Mikael Anttinen · Urologist/Turku University Hospital

MP01-04: Long-Term Gross Hematuria Improvements After Prostatic Artery Embolization: Comparing Results in Gland Volumes of &[le]80mL Versus >80mL

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Raj Ayyagari · Yale School of Medicine

MP01-05: Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Brendan L. Raizenne · University Of Montreal

MP01-06: Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia: 3 & 6 months outcomes.

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Eusebio Luna · Urological research Network

MP01-07: Factors associated with use of prostatic urethral lift (PUL)

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Samantha Thorogood · NewYork Presbyterian/Weill Cornell Medic

MP01-08: Convective Water Vapor Thermal Therapy (CWVTT) Improves Nocturia and Subjective Sleep Quality

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Aya Bsatee · OUHCOM

MP01-09: Risk Factors for A Delayed Improvement in Lower Urinary Tract Symptoms Following Convective Water Vapor Thermal Therapy

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Sarang Janakiraman · Loyola Medicine

MP01-10: Efficacy of Rezūm Water Vapor Thermal Therapy for Surgical Management of Benign Prostatic Hyperplasia in Prostates over 80 Grams

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Adam Jenks · SIU SCHOOL OF MEDICINE UROLOGY

MP01-11: Large, multi-center, prospective registry of Rezūm water vapor therapy benign prostatic enlargement

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Dean Elterman · University Of Toronto

MP01-12: Pharmacotherapy vs minimally invasive therapies as initial therapy for patients with benign prostate hyperplasia: a microsimulation model

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Dean Elterman · University Of Toronto

MP01-13: Comparison of Traditional Outcome Measures and Self-Assessed Goal Achievement in Patients Treated Surgically for Benign Prostatic Hyperplasia

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Manolis Pratsinis · Cantonal Hospital of St. Gallen

MP01-14: Association Between Industry Payments and Published Position on Use of Devices for the Treatment of Lower Urinary Tract Symptoms

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Armaan Singh · University of Chicago

MP01-15: Sedation as an alternative anesthetic technique for fragile patients in transurethral resection of the prostate

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Christian Ayoub · American University of Beirut Medical Center

MP01-16: Functional and surgical outcomes of Aquablation in elderly men

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Brendan L. Raizenne · University Of Montreal

MP01-17: Impact of ASA on Post-Operative HoLEP Outcomes and Complications

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Mary Soyster · Indiana University

MP01-18: GreenLight Photovaporization of the Prostate in High-Medical-Risk Patients: An analysis of the Global GreenLight Group (GGG) database

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
David-Dan Nguyen · University of Toronto

MP01-19: Minimally Invasive and Endoscopic Therapies for Benign Prostatic Hyperplasia: Head-to-Head Comparison of Short-Term Outcomes by Network Meta-Analysis

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Jamaal Jackson

MP01-20: A randomized controlled trial for opioid-limiting pain control after transurethral resection of the prostate: multimodal pain regimen with educational intervention versus standard of care

Friday, May 13, 2022 7:00 AM to 8:15 AM
Room 228
Adam Daily · Virginia Mason Franciscan Health